Tamoxifen use and risk of endometrial cancer in breast cancer patients: A systematic review and dose–response meta‐analysis

BACKGROUND: Worse prognosis of endometrial cancers (EC) in tamoxifen‐treated women compared to non‐tamoxifen‐treated women been proposed. The relationship between tamoxifen treatment of breast cancer (BC) and the risk of EC is controversial and there is no agreement between publication results on th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghanavati, Matin, Khorshidi, Yasaman, Shadnoush, Mahdi, Akbari, Mohammad Esmaeil, Ardehali, Seyed Hossein, Chavarri‐Guerra, Yanin, Akbari, Atieh, Barragan‐Carrillo, Regina, Amin Amlashi, Manoochehr, Javid, Zeinab, Rahmani, Jamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075294/
https://www.ncbi.nlm.nih.gov/pubmed/36916539
http://dx.doi.org/10.1002/cnr2.1806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075294/
https://www.ncbi.nlm.nih.gov/pubmed/36916539
http://dx.doi.org/10.1002/cnr2.1806

Ejemplares similares